reports
- GlobalData Department
Sygnis AG (LIO1) - Product Pipeline Analysis, 2018 Update
Summary Sygnis AG (Sygnis), formerly Sygnis Pharma AG is a developer of novel products and tools in the field of molecular biology. The company undertakes development and marketing of new molecular biological technologies for DNA amplification and sequencing. Its offers products such as single cell WGA kits, WGA kits, RCA kit, DNA polymerase, one step RT-PCR kit and one step RT-qPCR kit, single cell reverse transcriptase RNaseH+ and RNaseH- kits, among others. The company’s single cell WGA ki...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.